These documents are written in dense, lawyer-like language that requires individual interpretation from each function; ...

Validated biomarkers will help physicians identify patient subgroups that will benefit most from specific treatment ...

The fictional cases — which now carry corrections but remain published — are 'a huge stain on medical literature,' says one ...

Generative AI chatbots are now used by more than 987 million people globally, including around 64% of American teens, ...

Many researchers’ determination to prove a vaping-cancer link remains undimmed. They often seem only too willing to cut ...

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a new clinical case study ...

Every day, millions of people input prompts (whether questions or instructions) into AI tools such as ChatGPT, Perplexity, Claude, DALL-E, or Meta AI. Recently, media coverage highlighted what seemed ...

It is well known within the biopharma industry that clinical studies can produce any number of unexpected and possibly disappointing outcomes, including false negative results, or in statistical ...

For more than a century, people have considered Alzheimer's disease (AD) an irreversible illness. Consequently, research has focused on preventing or slowing it, rather than recovery. Despite billions ...

The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases. By Gina Kolata Gina Kolata has ...

The Trump administration’s latest effort to lower drug costs is expanding to biosimilars, medications that are highly similar to biologic drugs made with or isolated from living organisms such as ...